PPRS is a specialized firm providing R&D services in the pharmaceutical and medical device industries. In drug development, we offer end-to-end support, including preclinical research, clinical trials, and regulatory compliance. Our team has contributed to the development of over 50 molecules, ensuring rigorous testing for safety, efficacy, and market readiness. We guide clients through regulatory approval with agencies like the FDA and EMA, with a particular focus on innovative projects in neuroscience or orphan diseases.
 
In medical devices, PPRS designs, tests, and commercializes innovative solutions, with a strong emphasizes in software development and algorithms, with a strong focus on artificial intelligence (AI). ISO 13485 certified since 2020, we are committed to quality management systems for medical devices. We developed and commercialized Somno-Art, an ambulatory sleep analysis device, showcasing our ability to bring new products to market. We also provide preclinical testing, clinical evaluations, and post-market surveillance to ensure devices meet clinical and regulatory standards.
 
PPRS operates with a unique model combining scientific expertise, project management, and financial advisory services, including fundraising and negotiation. As a Strategic Partnering Organisation (SPO), we collaborate with clients to successfully develop both drug and medical device products. Focused on quality, compliance, and accelerated timelines, PPRS is dedicated to advancing solutions.
 
 
PPRS: www.pprs-research.com 
Somno-Art: www.somno-art.com 
The Siesta Group: www.thesiestagroup.com

PPRS Research

Org chart

Teams

Offices